Cheshire & Merseyside Bowel Cancer Screening Programme April 2008.

Slides:



Advertisements
Similar presentations
Paramedic Practitioner Support Scheme for Older People with Minor Injuries or Conditions South Yorkshire Ambulance Service NHS Trust Sheffield.
Advertisements

Implementing NICE guidance
Audit of patients diagnosed with colorectal cancer within the eligible age group for bowel cancer screening Clare Westwood Colorectal Nurse Consultant.
Breast Screening Programme, England, Statistics for : Graphs
National Cancer Screening Programmes Bowel Screening Breast Screening Cervical Screening.
Pathology in the UK Bowel Cancer Screening Programmes Frank Carey (Dundee)
Bowel Cancer & Bowel Cancer Screening Education and Awareness Sessions
Trust Cancer Lead Clinician
Bowel Cancer and Screening Dr M T Hendrickse Clinical Director/ Lead Colonoscopist Lancashire Bowel Screening Centre Blackpool Fylde and Wyre NHS Hospitals.
Bowel Cancer & Bowel Cancer Screening Education and Awareness Sessions.
Bowel Cancer and Screening
Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.
Wilson and Jungner Criteria for Screening 1968
Maureen Sayer Health Improvement Practitioner Cheshire and Merseyside Bowel Cancer Screening Programme.
The Bowel Cancer Screening Programme Professor Tony Morris Director, National Endoscopy Training Centre, Liverpool President, British Society of Gastroenterology.
Bowel Cancer & Bowel Cancer Screening Education and Awareness Sessions Maureen Sayer Health Improvement Practitioner Cheshire and Merseyside BCSP.
Bowel Cancer Screening Programme Cheshire and Merseyside NHS North West.
Bowel Screening in Scotland – Current Challenges and Possible Solutions Prof. Bob Steele Ninewells Hospital, University of Dundee.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas NICE CG March 2011.
Survivorship Update January 2015 The Royal Wolverhampton NHS Trust James Owen Senior Cancer Services Manager.
Overview of NHS Cervical Screening Programme Cervical Screening QARC Training School October 2012.
Increasing awareness and early diagnosis of cancer An update from Primary Care Jo Preston Service Improvement Facilitator NECN Dr Bill Hall Primary Care.
WLCCG Cancer QP Dr Pawan Randev WLCCG Cancer Lead GP 20 th June 2013.
Skin Cancer Network Group Audit of Clinical Performance Indicators: Data quality and treatment quality Anna Murray BSc Cancer Information Analyst
SETTING UP THE SERVICE BY LYNN TOBIN. HOW DID WE GET HERE? ABUNDENCE OF EVIDENCE PROVIDING JUSTIFICATION FOR BOWEL CANCER SCREENING.
1 Cervical Screening Programme, England, : Graphs.
PREPARED BY Colorectal Cancer Programme Screening for Colorectal Cancer A/P Susan Parry, Gastroenterologist, CD MOH Bowel Cancer Programme.
A National Bowel Screening Programme Anticipated Colonoscopy Volumes Susan Parry Gastroenterologist, Clinical Director, MOH Bowel Cancer Programme Emmanuel.
Healthy Communities Collaborative Promoting Earlier Presentation of Cancer Symptoms – Lung Breast and Bowel Tina Davies Senior Project Manager.
Cheshire & Merseyside Bowel Cancer Screening Programme April 2008.
Bowel Cancer Screening in West Herts- The First 2 Years! Alistair King Consultant Gastroenterologist.
Do all colorectal polyps require pathological examination? Aim To assess whether it is possible to omit the pathological examination of some polyps without.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
Breast Screening Programme Statistics for , England: Graphs.
Colorectal Cancer Screening Implementation of a public health programme An Expert Group on Colorectal Cancer Screening Cancer Society of Finland, Finnish.
Presentation title and subject Urology CNS Team October 2015 Kidney Pre-hab pilot at NBT.
Insert name of presentation on Master Slide Bowel Screening in Welsh Prisons Hayley Heard Head of Programme.
1st phase vs. 2nd phase Eligible patients identified: 87 vs. 118 The average waiting for an Oncology OPD was 67.4 days (SD:8.3 d) vs d. (SD:10.1.
FIT Programme (Faecal Immunohistochemical Test)
HEALTH DEVOLUTION: WHAT SHOULD PUBLIC AND PATIENT INVOLVEMENT LOOK LIKE DURING THIS ERA OF HEALTH AND SOCIAL CARE TRANSFORMATION Presentation to the All.
The capacity challenge:
Breast Screening Programme
Breast Screening Programme, England, Statistics for : Graphs
BOWEL SCOPE SCREENING Dorset BCSP
Nursing Home Dietetics Service update
Breast Screening Programme, England, Statistics for : Graphs
Colorectal Cancer Screening
Repeat Colonoscopy Recommendations
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 PRINCE CHARLES HOSPITAL (PCH) MDT.
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 YSBYTY GLAN CLWYD (YGC) MDT.
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 BRONGLAIS HOSPITAL (BRONGLAIS) MDT.
Volume 147, Issue 5, Pages e1 (November 2014)
Pathway for patients with suspected Breast Cancer
BOWEL CANCER SCREENING 11/7/18
NHS ADULT SCREENING PROGRAMMES
Pathway for patients with suspected Upper GI (OG) Cancer
Bowel Screening in Wales
Volume 147, Issue 5, Pages e1 (November 2014)
What to look out for and why?
Colorectal Cancer Cancer Alliance Work
Worcestershire Colorectal Cancer 2ww Pathway
Patient Education and Support following treatment for Skin Cancer
Victor L. Fox, Stephen Perros, Hongyu Jiang, Jeffrey D. Goldsmith 
Pathway for patients with suspected Breast Cancer
Louise Newton & Cathy Corcoran
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Colorectal 2 week wait pathways and “Getting FIT”
Presentation transcript:

Cheshire & Merseyside Bowel Cancer Screening Programme April 2008

Cancer Reform Strategy Changes Extending screening from 2010 to year olds Extending screening from 2010 to year olds 62 day waits to apply – end day waits to apply – end 2008 Consideration of people in their 50s is next step Consideration of people in their 50s is next step – Flexi-sig trial results will be available in 2/3 years Immunological testing and CT colography to be considered in due course Immunological testing and CT colography to be considered in due course

Cheshire & Merseyside Programme Total population of 2.38 million Screening population of 330,000 Working across 8 Primary Care Trusts 18 PCT-based clinics 11 colonoscopy lists per week at RLH, Aintree and Leighton

Cheshire and Merseyside BCSP Clinical Statistics from September March 2008 Overall Uptake rate 55% Overall Uptake rate 55% 1268 patients seen in nurse led clinics following FOB positive result 1268 patients seen in nurse led clinics following FOB positive result 1215 colonoscopies performed 1215 colonoscopies performed 38 patients refused to have colonoscopy (2.6%) 38 patients refused to have colonoscopy (2.6%) 31 patients deemed clinically inappropriate (2.1%) 31 patients deemed clinically inappropriate (2.1%) 15 patients had completion barium enema (1%) 15 patients had completion barium enema (1%)

NEOPLASIA Total number of adenomatous polyps removed = 1330 (498 patients ) Total number of adenomatous polyps removed = 1330 (498 patients ) Total number of hyperplastic polyps removed =314 Total number of hyperplastic polyps removed =314 Total number of malignant polyps removed= 21 patients Total number of malignant polyps removed= 21 patients

Patient Outcomes 10% patients to have 1 year surveillance (High risk polyps) 10% patients to have 1 year surveillance (High risk polyps) 18% patients to have 3 year surveillance (Intermediate risk polyps) 18% patients to have 3 year surveillance (Intermediate risk polyps) 60% to return to screening programme with 2 yearly invitation to repeat participation in screening ( Low risk polyps) 60% to return to screening programme with 2 yearly invitation to repeat participation in screening ( Low risk polyps) 12% referred to local MDT for cancer treatment ( 141 patients ) 12% referred to local MDT for cancer treatment ( 141 patients )

Duke Staging of CRC on BCSP Duke A 53% (including malignant polyps) Duke A 53% (including malignant polyps) Duke B 21.4% Duke B 21.4% Duke C 21.4% Duke C 21.4% Duke D 4.2% Duke D 4.2% These figures are based upon 115 patients who had undergone surgery at time of audit and had definitive post-operative staging. These figures are based upon 115 patients who had undergone surgery at time of audit and had definitive post-operative staging.

Central and Eastern Cheshire PCT Screening Uptake Total screening population 65,134 Total screening population 65,134 April -June 07 =40.0% April -June 07 =40.0% July - Sep 07 =56.00% July - Sep 07 =56.00% Oct - Dec 07 =59.00% Oct - Dec 07 =59.00% Jan - March 08 =60.00% Jan - March 08 =60.00%

Central and Eastern Cheshire PCT Activity April 2007 _ March 2008 April 2007 _ March 2008 Total invitations sent 29,872 Total invitations sent 29,872 Self Referrals (over 70’s) 736 Self Referrals (over 70’s) 736 FOB Positive patients 290 FOB Positive patients 290 Nurse Clinic Attendance 216 Nurse Clinic Attendance 216 Colonoscopy Performed 213 Colonoscopy Performed 213 (including surveillance ) (including surveillance )

Central and Eastern Cheshire PCT Adenomas removed from patients = 99 Adenomas removed from patients = 99 Cancers detected = 27 Cancers detected = 27

CENTRAL AND EASTERN CHESHIRE PCT DUKES CLASSIFICATION DUKES A = 53.8% DUKES A = 53.8% DUKES B = 46.2% DUKES B = 46.2% DUKES C = 0% DUKES C = 0% DUKES D = 0% DUKES D = 0% Total number of MDT referrals to date = 23 Total number of MDT referrals to date = 23

WESTERN CHESHIRE PCT SCREENING UPTAKE Total screening population 35,470 Total screening population 35,470 July - Sep 07 =49.00% July - Sep 07 =49.00% Oct - Dec 07 =56.00% Oct - Dec 07 =56.00% Jan - March 08 =59.00% Jan - March 08 =59.00%

Western Cheshire PCT July 2007 _ March 2008 July 2007 _ March 2008 Total invitations sent 14,825 Total invitations sent 14,825 Self Referrals (over 70’s) 431 Self Referrals (over 70’s) 431 FOB Positive patients 145 FOB Positive patients 145 Nurse Clinic Attendance 95 Nurse Clinic Attendance 95 Colonoscopy Performed 87 Colonoscopy Performed 87 (including surveillance ) (including surveillance )

Western Cheshire PCT Activity Adenomas removed from patients = 34 Adenomas removed from patients = 34 Cancers detected = 12 Cancers detected = 12

WESTERN CHESHIRES DUKES CLASSIFICATION DUKES A = 87.5% DUKES A = 87.5% DUKES B = 0% DUKES B = 0% DUKES C = 12.5% DUKES C = 12.5% DUKES D = 0% DUKES D = 0% Total number of MDT referrals to date = 18 Total number of MDT referrals to date = 18

RLBUH DUKES CLASSIFICATION DUKES A = 52.17% DUKES A = 52.17% DUKES B = 8.69% DUKES B = 8.69% DUKES C = 34.8% DUKES C = 34.8% DUKES D = 4.34% DUKES D = 4.34% Total number of MDT referrals to date = 31 Total number of MDT referrals to date = 31

UHA DUKES CLASSIFICATION DUKES A = 53.3% DUKES A = 53.3% DUKES B = 20.0% DUKES B = 20.0% DUKES C = 26.7% DUKES C = 26.7% DUKES D = 0% DUKES D = 0% Total number of Liverpool MDT referrals to date = 23 (Sefton patients not included = 6) Total number of Liverpool MDT referrals to date = 23 (Sefton patients not included = 6)

Further Information